Drugplain

Belladonna and Opium 16.2 mg/1

ATROPA BELLADONNA and OPIUM · SUPPOSITORY · Bryant Ranch Prepack

No Recall History
Plain English

Belladonna and Opium suppositories are a prescription rectal medication that combines two active ingredients to help relieve pain and reduce muscle spasms, particularly for conditions affecting the lower bowel and urinary tract. This combination product has been used historically for certain types of abdominal and pelvic pain, though it is now rarely prescribed due to the availability of newer pain management options.

Key Facts

Brand Name
Belladonna and Opium
Generic Name
ATROPA BELLADONNA and OPIUM
NDC Code (Product)
63629-8436
Manufacturer
Bryant Ranch Prepack
Strength
16.2 mg/1
Dosage Form
SUPPOSITORY
Route
RECTAL
Marketing Status
DEA Schedule
Schedule II (Controlled)
Marketing Start
05/01/1994

Recall History

No Recall History

Frequently Asked Questions

What is Belladonna and Opium used for?

Belladonna and Opium suppositories are a prescription rectal medication that combines two active ingredients to help relieve pain and reduce muscle spasms, particularly for conditions affecting the lower bowel and urinary tract. This combination product has been used historically for certain types of abdominal and pelvic pain, though it is now rarely prescribed due to the availability of newer pain management options.

Is Belladonna and Opium a controlled substance?

Yes, Belladonna and Opium is classified as CII under the DEA Controlled Substances Act.

What is the generic name for Belladonna and Opium?

The generic name for Belladonna and Opium is ATROPA BELLADONNA and OPIUM. There are no other listed brand versions of ATROPA BELLADONNA and OPIUM.

What is the NDC code for Belladonna and Opium 16.2 mg/1?

The NDC (National Drug Code) for Belladonna and Opium 16.2 mg/1 is 63629-8436, listed by Bryant Ranch Prepack.

Product NDC

63629-8436

Package NDC

63629-8436-1

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)